Effectiveness of mRNA COVID-19 Monovalent and Bivalent Vaccine Booster Doses Against Omicron Severe Outcomes Among Adults Aged ≥50 Years in Ontario, Canada: A Canadian Immunization Research Network Study
dc.contributor.author | Grewal, Ramandip | |
dc.contributor.author | Buchan, Sarah A | |
dc.contributor.author | Nguyen, Lena | |
dc.contributor.author | Nasreen, Sharifa | |
dc.contributor.author | Austin, Peter C | |
dc.contributor.author | Brown, Kevin A | |
dc.contributor.author | Gubbay, Jonathan | |
dc.contributor.author | Lee, Nelson | |
dc.contributor.author | Schwartz, Kevin L | |
dc.contributor.author | Tadrous, Mina | |
dc.contributor.author | Wilson, Kumanan | |
dc.contributor.author | Wilson, Sarah E | |
dc.contributor.author | Kwong, Jeffrey C | |
dc.date.accessioned | 2024-06-24T16:35:14Z | |
dc.date.available | 2024-06-24T16:35:14Z | |
dc.date.issued | 2023-10-05 | |
dc.identifier.citation | Grewal R, Buchan SA, Nguyen L, Nasreen S, Austin PC, Brown KA, Gubbay J, Lee N, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC. Effectiveness of mRNA COVID-19 Monovalent and Bivalent Vaccine Booster Doses Against Omicron Severe Outcomes Among Adults Aged ≥50 Years in Ontario, Canada: A Canadian Immunization Research Network Study. J Infect Dis. 2024 Feb 14;229(2):394-397. doi: 10.1093/infdis/jiad419. PMID: 37798119; PMCID: PMC10873169. | en_US |
dc.identifier.issn | 0022-1899 | |
dc.identifier.eissn | 1537-6613 | |
dc.identifier.doi | 10.1093/infdis/jiad419 | |
dc.identifier.pmid | 37798119 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12648/14975 | |
dc.description.abstract | We estimated the effectiveness of booster doses of monovalent and bivalent mRNA COVID-19 vaccines against Omicron-associated severe outcomes among adults aged ≥50 years in Ontario, Canada. Monovalent and bivalent mRNA COVID-19 booster doses provided similar strong initial protection against severe outcomes. Uncertainty remains around waning of protection from these vaccines. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Oxford University Press (OUP) | en_US |
dc.relation.url | https://academic.oup.com/jid/article/229/2/394/7292964 | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | COVID-19 | en_US |
dc.subject | omicron | en_US |
dc.subject | bivalent | en_US |
dc.subject | mRNA | en_US |
dc.subject | vaccine effectiveness | en_US |
dc.title | Effectiveness of mRNA COVID-19 Monovalent and Bivalent Vaccine Booster Doses Against Omicron Severe Outcomes Among Adults Aged ≥50 Years in Ontario, Canada: A Canadian Immunization Research Network Study | en_US |
dc.type | Article/Review | en_US |
dc.source.journaltitle | The Journal of Infectious Diseases | en_US |
dc.source.volume | 229 | |
dc.source.issue | 2 | |
dc.source.beginpage | 394 | |
dc.source.endpage | 397 | |
dc.description.version | VoR | en_US |
refterms.dateFOA | 2024-06-24T16:35:16Z | |
dc.description.institution | SUNY Downstate | en_US |
dc.description.department | Epidemiology and Biostatistics | en_US |
dc.description.degreelevel | N/A | en_US |
dc.identifier.issue | 2 | en_US |